Trial Profile
Lopinavir/ritonavir or Efavirenz containing antiretroviral therapy regimen on the pharmacokinetics of etonogestrel-releasing implant in HIV-positive women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 29 Dec 2015 New trial record